Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function

Table 1

Patient characteristics at baseline.

Patient ID	Gender/age (years)/diagnosis	Body mass index (kg/m^2)	Small bowel (cm)	Colon-in cont. (%)	Time since last surgery (years)	Wet weight intake (kg/d)	Fecal wet weight excretion (kg/d)	Parenteral fluid (L/d)	Diet energy intake (MJ/d)	Fecal energy excretion (MJ/d)	Patenteral energy (MJ/d)	Duration of HPN (years)	Time on GLP-2(days, 365+365 ∼2 years)
HRM	F/47/CD	21.3	150	0	2.5	5.2	3.7	1.0	13.5	7.1	0.8	2.5	365+365
LM	M/27/CD	21.0	70	75	2.5	3.9	2.3	2.3	11.8	6.0	6.4	2.5	365+365
OB	M/49/CD	25.5	150	0	11.6	3.1	1.3	0.5	13.2	4.6	0.0	11.6	232+0, Abd. pain
GL	M/53/CD	17.3	180	0	20.6	3.2	1.6	no	16.8	4.4	no	no	365+365
JP	M/24/CD	20.4	130	100	2.3	3.1	0.7	1.8	16.4	4.6	4.5	2.3	365+160, Abd. pain
EFP	F/55/CD	17.5	50	0	0.5	2.2	4.9	3.1	8.0	7.1	5.5	1.7	365+174, unrel. feedback
JE	M/44/UC compl.	27.2	200	0	1.6	5.9	3.9	no	13.8	5.5	no	no	365+365
JHJ	M/55/UC compl.	22.2	200	0	2.3	4.6	1.9	1.3	17.8	2.8	0.4	2.3	365+365
UDJ	F/50/UC compl.	25.8	150	0	0.9	2.8	2.2	2.9	8.8	2.2	2.7	2.9	365+365
JV	M/67/CD	22.6	180	0	12.1	8.7	7.1	no	28.2	18.1	no	no	365+365
FVL	M/59/CD	20.1	290	0	5.8	3.1	1.2	no	7.8	1.3	no	no	365+365

M: male, F: female, CD: Crohns disease, UC compl.: Ulcerative colitis complications, Abd. Pain: Abdominal pain, Unrel. Feedback: Unreliable feedback.